
Kreton Mavromatis MD
Interventional Cardiology
Professor, Medicine, Emory University School of Medicine
Join to View Full Profile
1365 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-5299
Fax+1 404-778-5490
Dr. Mavromatis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Emory University School of MedicineFellowship, Cardiovascular Disease, 1997 - 2001
- University of WashingtonResidency, Internal Medicine, 1994 - 1997
- University of Michigan Medical SchoolClass of 1994
Certifications & Licensure
- GA State Medical License 1997 - 2025
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients Start of enrollment: 2003 Jan 01
- Age and Endothelial Progenitor Cell Mobilization Start of enrollment: 2006 Jul 01
- Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty Start of enrollment: 2012 Jan 11
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsInvasive vs Conservative Management of Patients With Chronic Total Occlusion: Results From the ISCHEMIA Trial.Sripal Bangalore, G B John Mancini, Jonathan Leipsic, Mathew J Budoff, Yifan Xu
Journal of the American College of Cardiology. 2025-04-01 - 1 citationsGuideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial.David J Maron, Jonathan D Newman, Rebecca Anthopolos, Ying Lu, Susanna Stevens
Journal of the American College of Cardiology. 2025-04-01 - Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, op...William F Fearon, Frederik M Zimmermann, Victoria Y Ding, Kuniaki Takahashi, Zsolt Piroth
Lancet. 2025-03-28
Press Mentions
- Cath Lab Attire: ‘Dress up and Shut Up’ or Time for a Change?March 28th, 2025
- In ISCHEMIA Population, Invasive Group Benefits from Complete RevascularizationJune 16th, 2021
- NCDR Study Examines Link Between MR and Mortality, Rehab in TAVR PatientsJanuary 11th, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: